Abstract
A trial of telmisartan prevention of cardiovascular disease (ATTEMPT-CVD) was performed to compare the effects of angiotensin II receptor blocker (ARB) therapy and those of non-ARB standard therapy on biomarker level changes and the incidence of cardiovascular events in hypertensive patients. In this multicenter, open-label, randomized, parallel-group, comparative study, the effects of ARB therapy and those of non-ARB standard therapy on urinary albumin creatinine ratio (UACR) and plasma brain natriuretic peptide (BNP) level changes were investigated for three years from the start of antihypertensive treatment as the primary endpoints. The incidences of cardiovascular composite events were compared between the two groups, and the relationship between the incidence of the events and biomarker changes were investigated as secondary endpoints. The study started with 615 patients in the ARB group and 613 patients in the non-ARB group. The ARB group had a significant effect on UACR and plasma BNP level changes compared with the non-ARB group. Fewer cardiovascular events occurred in the ARB group, but the difference was not statistically significant. UACR and plasma BNP levels at baseline were associated with cardiovascular events. T...Continue Reading
References
Jul 15, 1997·Circulation·T TsutamotoM Kinoshita
Jul 31, 2001·JAMA : the Journal of the American Medical Association·H C GersteinUNKNOWN HOPE Study Investigators
Sep 13, 2002·Journal of the American College of Cardiology·Margaret M RedfieldJohn C Burnett
Oct 29, 2002·Diabetes Care·Ferdinando C SassoDomenico Cozzolino
Nov 6, 2002·Circulation·Roberto LatiniUNKNOWN Valsartan Heart Failure Trial Investigators
Dec 24, 2004·Diabetes Care·Jorge L GrossThemis Zelmanovitz
Jan 19, 2005·Hypertension·Hans IbsenYing Wan
Feb 18, 2005·The New England Journal of Medicine·Charlotte KragelundRolf Steffensen
Nov 23, 2006·European Journal of Echocardiography : the Journal of the Working Group on Echocardiography of the European Society of Cardiology·Phivos SymeonidesDemosthenes Katritsis
May 9, 2007·American Journal of Hypertension·Yuichiro YanoKazuomi Kario
Apr 2, 2008·The New England Journal of Medicine·UNKNOWN ONTARGET InvestigatorsCraig Anderson
Nov 8, 2008·American Journal of Hypertension·Christian DellesRoland E Schmieder
Jan 22, 2009·Journal of Hypertension·Emmanuel A AndreadisEmmanuel J Diamantopoulos
Nov 18, 2009·Circulation·Emanuele Di AngelantonioJohn Danesh
Aug 23, 2011·European Journal of Preventive Cardiology·Martin ClodiRichard Pacher
Apr 10, 2013·European Journal of Heart Failure·Andreas LuchnerIris M Heid
Jun 4, 2013·Journal of the American College of Cardiology·Omair YousufMatthew J Budoff
Sep 13, 2014·Journal of the American College of Cardiology·Kevin DammanJohn J V McMurray
Citations
Jan 22, 2019·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Shokei Kim-MitsuyamaKunihiko Matsui
Jan 26, 2018·Scientific Reports·Mun Hee ChoiJi Man Hong
Feb 18, 2018·Scientific Reports·Shokei Kim-MitsuyamaKunihiko Matsui
Feb 28, 2020·The Cochrane Database of Systematic Reviews·Meaghan LunneyPietro Ravani
Nov 14, 2019·Scientific Reports·Shokei Kim-MitsuyamaKunihiko Matsui
Oct 14, 2020·Scientific Reports·Shokei Kim-MitsuyamaKunihiko Matsui